Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UCHL1 | P09936 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HTR2B | P41595 | 2/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 5/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 5/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24010364 | 0.94 | HTR2C (0.39) | UCHL1MEN1KMT2AALDH1A1HTR2C | |
| SCHEMBL25820817 | 0.91 | UCHL1 (0.41) | UCHL1MEN1KMT2AALDH1A1HTR2C | |
| SCHEMBL25820804 | 0.89 | UCHL1 (0.45) | UCHL1MEN1KMT2AALDH1A1HTR2C | |
| SCHEMBL24010363 | 0.85 | HTR2C (0.38) | UCHL1ALDH1A1HTR2CSMN1; SMN2HTR2B | |
| SCHEMBL25827157 | 0.85 | HTR2C (0.40) | UCHL1MEN1KMT2AHTR2CTSHR | |
| SCHEMBL25820812 | 0.85 | MEN1 (0.43) | MEN1KMT2AALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL25820779 | 0.81 | DNMT1 (0.42) | UCHL1MEN1KMT2AALDH1A1 | |
| SCHEMBL25820801 | 0.81 | UCHL1 (0.43) | UCHL1MEN1KMT2AHTR2CTSHR | |
| SCHEMBL25820778 | 0.81 | ALDH1A1 (0.50) | UCHL1ALDH1A1TSHR | |
| SCHEMBL24010366 | 0.79 | CYP11B2 (0.40) | MEN1KMT2AALDH1A1HTR2CTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219927-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219927-A1 | AKT3 MODULATORS | AKT3, AKT2, PIK3CA | UCHL1 4725/4885MEN1 1172/4885KMT2A 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.